# Cerba

> World\-class clinical research that helps life science companies to successfully develop the predictive and precision medicines of the future\.

Generated by Yoast SEO v28.7, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Next\-generation Sequencing \(NGS\)](https://www.cerbaresearch.com/solutions/specialty-lab-testing/genomics/ngs/)
- [Home](https://www.cerbaresearch.com/)
- [Scientific Publications](https://www.cerbaresearch.com/knowledge-center/scientific-publications/)
- [Clinical Trial Logistics](https://www.cerbaresearch.com/solutions/centralized-lab-management/logistics/)
- [Biospecimens](https://www.cerbaresearch.com/solutions/centralized-lab-management/biospecimens/)

## Blogs
- [Insights from CYTO 2026: The Future of Flow Cytometry Demands Greater Scale, Standardization, and Smarter Analysis](https://www.cerbaresearch.com/knowledge-center/blog/insights-from-cyto-2026-the-future-of-flow-cytometry-demands-greater-scale-standardization-and-smarter-analysis/)
- [Flow Matters: How Flow Cytometry Enables Precision Across the AML Clinical Trial Journey](https://www.cerbaresearch.com/knowledge-center/blog/flow-cytometry-aml-clinical-trials/)
- [Flow Matters: The Power of Flow Cytometry in MRD Detection in Oncology](https://www.cerbaresearch.com/knowledge-center/blog/the-power-of-flow-cytometry-in-mrd-detection-in-oncology/)
- [Leveraging the Power of Automation to Boost Research](https://www.cerbaresearch.com/knowledge-center/blog/revolutionizing-clinical-trial-logistics-with-automation/)
- [Exploring the Potential for AI and Automation in the Laboratory](https://www.cerbaresearch.com/knowledge-center/blog/future-forward-unlocking-the-power-of-ai-in-the-lab/)

## Brochures
- [Immuno\-oncology Clinical Trials: Managing Specialty and Central Lab Services](https://www.cerbaresearch.com/brochure/h1-white-paper-template/)
- [Logistics Solutions for Sample \& Kit Management](https://www.cerbaresearch.com/brochure/logistics-solutions-for-sample-kit-management/)
- [Meeting the Challenges You Face with Global PBMC](https://www.cerbaresearch.com/brochure/meeting-the-challenges-you-face-with-global-pbmc-2/)
- [Genomics Services at Cerba Research](https://www.cerbaresearch.com/brochure/genomics-services-at-cerba-research/)
- [Highly Sensitive HPV Detection and Genotyping](https://www.cerbaresearch.com/brochure/highly-sensitive-hpv-detection-and-genotyping/)

## Factsheets
- [Unveiling the Oncology Journey: Highlighting Cutting\-edge Capabilities](https://www.cerbaresearch.com/fact-sheet/unveiling-the-oncology-journey-highlighting-cutting-edge-capabilities/)
- [Unlocking The Potential Of Rare Disease Drug Development](https://www.cerbaresearch.com/fact-sheet/unlocking-the-potential-of-rare-disease-drug-development/)
- [Advancing Cell \& Gene Therapy Trials With Confidence](https://www.cerbaresearch.com/fact-sheet/advancing-cell-gene-therapy-trials-with-confidence/)
- [Discover our Hematological Malignancies Trial Portfolio with Cutting\-Edge Laboratory Solutions](https://www.cerbaresearch.com/fact-sheet/discover-our-hematological-malignancies-trial-portfolio-with-cutting-edge-laboratory-solutions/)
- [Advancing Your Solid Tumor Trials With Our Cutting\-Edge Assay Portfolio](https://www.cerbaresearch.com/fact-sheet/advancing-your-solid-tumor-trials-with-our-cutting-edge-assay-portfolio/)

## Flyers
- [Central Lab Division NASH Research](https://www.cerbaresearch.com/flyer/central-lab-division-nash-research/)

## Guides
- [The Cost of a Late Start: IVDR Compliance for Laboratory\-developed Tests](https://www.cerbaresearch.com/guide/the-cost-of-a-late-start-ivdr-compliance-for-laboratory-developed-tests/)
- [A Best Practice Guide for Laboratory Services in Oncology Trials](https://www.cerbaresearch.com/guide/a-best-practice-guide-for-laboratory-services-in-oncology-trials/)

## Lists
- [Comprehensive View of our Immunohistochemistry Biomarkers](https://www.cerbaresearch.com/resource-list/comprehensive-view-of-our-immunohistochemistry-biomarkers/)
- [Off\-the\-Shelf 37\-plex MSD Panel](https://www.cerbaresearch.com/resource-list/off-the-shelf-37-plex-msd-panel/)
- [Breast Cancer Biomarkers](https://www.cerbaresearch.com/resource-list/breast-cancer-biomarkers/)
- [Colorectal Cancer Biomarkers](https://www.cerbaresearch.com/resource-list/colorectal-cancer-biomarkers/)
- [Lung Cancer Biomarkers](https://www.cerbaresearch.com/resource-list/lung-cancer-biomarkers/)

## News
- [Cerba Research Expands Global Spectral Flow Cytometry Capabilities with Additional Cytek Aurora™ Evo Instruments](https://www.cerbaresearch.com/news-events/news-articles/cerba-research-expands-global-spectral-flow-cytometry-capabilities-with-additional-cytek-aurora-evo-instruments/)
- [Cerba Research Awarded NIH Contract for Central Lab Services](https://www.cerbaresearch.com/news-events/news-articles/cerba-research-awarded-nih-contract-for-central-lab-services/)
- [Cerba Research Delivers Key Data for Clover’s Phase 1 RSV‑hMPV±PIV3 Combination Vaccines Study](https://www.cerbaresearch.com/news-events/news-articles/cerba-research-delivers-key-data-for-clovers-phase-1-rsv-hmpv±piv3-combination-vaccines-study/)
- [Cerba Research Launches Redesigned Website to Give Sponsors Quicker Access to Scientific Expertise](https://www.cerbaresearch.com/news-events/news-articles/cerba-research-launches-redesigned-website-to-give-sponsors-faster-access-to-scientific-expertise/)

## Our Leadership
- [Lorella Di Donato](https://www.cerbaresearch.com/our-leadership/lorella-di-donato/)
- [Charlotte Michel](https://www.cerbaresearch.com/our-leadership/charlotte-michel/)
- [Maria Fotiu](https://www.cerbaresearch.com/our-leadership/maria-fotiu/)
- [Teresa Dunlap](https://www.cerbaresearch.com/our-leadership/teresa-dunlap/)
- [Jenny de Pessemier](https://www.cerbaresearch.com/our-leadership/jenny-de-pessemier/)

## Posters
- [Clinical performance of three automated screening assays for antibodies against nuclear antigens](https://www.cerbaresearch.com/poster/clinical-performance-of-three-automated-screening-assays-for-antibodies-against-nuclear-antigens/)

## Press Release
- [Cerba Research Announces Time‑Saving COVID‑19 Exploratory Tools and NGS Advancements](https://www.cerbaresearch.com/news-events/press-releases/cerba-research-announces-time-saving-covid-19-exploratory-tools-and-ngs-advancements/)
- [Viroclinics\-DDL Changes Name to Cerba Research](https://www.cerbaresearch.com/news-events/press-releases/viroclinics-ddl-changes-name-to-cerba-research/)
- [Cerba Research and Ozette Technologies Partnership](https://www.cerbaresearch.com/news-events/press-releases/cerba-research-and-ozette-technologies-partnership/)
- [Cerba HealthCare to Acquire Canadian Contract Research Laboratory CIRION BioPharma Research](https://www.cerbaresearch.com/news-events/press-releases/news-events-press-releases-cerba-healthcare-to-acquire-canadian-contract-research-laboratory-cirion-biopharma-research/)
- [Cerba HealthCare Acquires Viroclinics\-DDL](https://www.cerbaresearch.com/news-events/press-releases/cerba-healthcare-acquires-viroclinics-ddl-cerba-research/)

## Reports
- [Overcoming Immunogenicity and Safety Assessment Challenges for Biologics and Biosimilars in Oncology](https://www.cerbaresearch.com/report/overcoming-immunogenicity-and-safety-assessment-challenges-for-biologics-and-biosimilars-in-oncology/)
- [Mitigating Immunogenicity Risk Factors in AAV Gene Therapy Clinical Trials](https://www.cerbaresearch.com/report/mitigating-immunogenicity-risks-factors-in-aav-gene-therapy-clinical-trials/)
- [Infectious Disease Clinical Trials: Navigating Innovation and Rising Complexity](https://www.cerbaresearch.com/report/infectious-disease-clinical-trials-navigating-innovation-rising-complexity/)

## Webinar
- [Immuno\-Oncology Biomarkers: From Exploratory Research to Trials](https://www.cerbaresearch.com/knowledge-center/webinar/immuno-oncology-biomarkers-research-to-trials/)
- [IVDR Compliance for Custom LDT Assays](https://www.cerbaresearch.com/knowledge-center/webinar/ivdr-compliance-for-custom-ldt-assays/)
- [Advancing CAR T\-Cell Therapies with Clinical Trial Customization](https://www.cerbaresearch.com/knowledge-center/webinar/advancing-cart-t-cell-therapies-clinical-trial-customization/)
- [Analyzing Multiple Biomarkers with IHC: Putting a 6\-Plex Kit to the Challenge](https://www.cerbaresearch.com/knowledge-center/webinar/analyzing-multiple-biomarkers-with-ihc-putting-a-6-plex-kit-to-the-challenge/)
- [Overcoming Bioanalytical Challenges in Anti\-Drug Antibody Detection for ADCs](https://www.cerbaresearch.com/knowledge-center/webinar/overcoming-bioanalytical-challenges-in-anti-drug-antibody-detection-for-adcs/)

## Whitepapers
- [COVID\-19 Therapy Development and Clinical Diagnostics](https://www.cerbaresearch.com/knowledge-center/whitepaper/covid-19-therapy-development-and-clinical-diagnostic/)
- [Decoding a B\-Cell Fingerprint](https://www.cerbaresearch.com/knowledge-center/whitepaper/decoding-a-b-cell-fingerprint-tcr-sequencing-2023-04_wp/)
- [Precision Medicine for Non\-small Cell Lung Cancer \(NSCLC\)](https://www.cerbaresearch.com/knowledge-center/whitepaper/precision-medicine-for-non-small-cell-lung-cancer-nsclc/)
- [Translating Scientific Questions into Preclinical Experiments](https://www.cerbaresearch.com/knowledge-center/whitepaper/translating-scientific-questions-into-preclinical-experiments/)
- [Decoding a T\-Cell Fingerprint](https://www.cerbaresearch.com/knowledge-center/whitepaper/decoding-a-t-cell-fingerprint/)

## Content Type
- [Insight](https://www.cerbaresearch.com/content-type/insight/)
- [Event digest](https://www.cerbaresearch.com/content-type/event-digest/)
- [Interview](https://www.cerbaresearch.com/content-type/interview/)

## Services
- [Flow cytometry](https://www.cerbaresearch.com/services/flow-cytometry/)
- [Assay development and technology transfer](https://www.cerbaresearch.com/services/assay-development-and-technology-transfer/)
- [Biomarkers](https://www.cerbaresearch.com/services/biomarkers/)
- [Specialty lab testing](https://www.cerbaresearch.com/services/specialty-lab-testing/)
- [Next–generation sequencing](https://www.cerbaresearch.com/services/next-generation-sequencing/)

## Therapeutic Areas
- [Oncology](https://www.cerbaresearch.com/?taxonomy=therapeutic_areas&term=oncology)
- [Immuno\-oncology](https://www.cerbaresearch.com/?taxonomy=therapeutic_areas&term=immunooncology)
- [Infectious diseases](https://www.cerbaresearch.com/?taxonomy=therapeutic_areas&term=infectious-diseases)
- [Cell and gene therapy](https://www.cerbaresearch.com/?taxonomy=therapeutic_areas&term=cell-and-gene-therapy)
- [Rare diseases](https://www.cerbaresearch.com/?taxonomy=therapeutic_areas&term=rare-diseases)

## Topics
- [Artificial intelligence \(AI\)](https://www.cerbaresearch.com/topics/artificial-intelligence-ai/)
- [Partnership](https://www.cerbaresearch.com/topics/partnership/)
- [Global footprint](https://www.cerbaresearch.com/topics/global-footprint/)
- [Operational excellence](https://www.cerbaresearch.com/topics/operational-excellence/)
- [Automation](https://www.cerbaresearch.com/topics/automation/)

## Optional
- [Sitemap index](https://www.cerbaresearch.com/sitemap_index.xml)